An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects with Intermediate Age-Related Macular Degeneration
Clinical Trial Grant
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Stealth BioTherapeutics
Start Date
September 1, 2016
End Date
August 31, 2022
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Stealth BioTherapeutics
Start Date
September 1, 2016
End Date
August 31, 2022